Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Change in Cash (2016 - 2025)

Historic Change in Cash for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$625000.0.

  • Harvard Bioscience's Change in Cash fell 21996.16% to -$625000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 39156.94%. This contributed to the annual value of -$175000.0 for FY2024, which is 2222.22% up from last year.
  • As of Q3 2025, Harvard Bioscience's Change in Cash stood at -$625000.0, which was down 21996.16% from $1.9 million recorded in Q2 2025.
  • Harvard Bioscience's Change in Cash's 5-year high stood at $2.3 million during Q4 2021, with a 5-year trough of -$2.5 million in Q1 2021.
  • Moreover, its 5-year median value for Change in Cash was -$207000.0 (2024), whereas its average is -$78947.4.
  • In the last 5 years, Harvard Bioscience's Change in Cash tumbled by 48926.55% in 2021 and then skyrocketed by 523571.43% in 2025.
  • Over the past 5 years, Harvard Bioscience's Change in Cash (Quarter) stood at $2.3 million in 2021, then plummeted by 127.98% to -$636000.0 in 2022, then plummeted by 66.19% to -$1.1 million in 2023, then soared by 56.39% to -$461000.0 in 2024, then plummeted by 35.57% to -$625000.0 in 2025.
  • Its Change in Cash stands at -$625000.0 for Q3 2025, versus $1.9 million for Q2 2025 and $1.4 million for Q1 2025.